S
Sayit Mahmut Erdoğan
Researcher at Copenhagen University Hospital
Publications - 2
Citations - 61
Sayit Mahmut Erdoğan is an academic researcher from Copenhagen University Hospital. The author has contributed to research in topics: Plasmodium falciparum & Immune system. The author has an hindex of 1, co-authored 2 publications receiving 20 citations. Previous affiliations of Sayit Mahmut Erdoğan include University of Copenhagen & Laos Ministry of Agriculture and Forestry.
Papers
More filters
Journal ArticleDOI
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.
Cyrielle Fougeroux,Louise Goksøyr,Manja Idorn,Vladislav Soroka,Sebenzile K. Myeni,Robert Dagil,Christoph M. Janitzek,Max Søgaard,Kara Lee Aves,Emma W. Horsted,Sayit Mahmut Erdoğan,Sayit Mahmut Erdoğan,Tobias Gustavsson,Jerzy Dorosz,Stine B. Clemmensen,Laurits Fredsgaard,Susan Thrane,Elena Ethel Vidal-Calvo,Paul Khalifé,Thomas M. Hulen,Swati Choudhary,Michael Theisen,Susheel K. Singh,Asier Garcia-Senosiain,Linda van Oosten,Gorben P. Pijlman,Bettina Hierzberger,Tanja Domeyer,Blanka W. Nalewajek,Anette Strøbæk,Magdalena Skrzypczak,Laura F. Andersson,Søren Buus,Anette Stryhn Buus,Jan Pravsgaard Christensen,Tim J. Dalebout,Kasper Iversen,Lene Holm Harritshøj,Benjamin Mordmüller,Henrik Ullum,Line S. Reinert,Willem A. de Jongh,Marjolein Kikkert,Søren R. Paludan,Thor G. Theander,Morten Nielsen,Ali Salanti,Adam F. Sander +47 more
TL;DR: In this paper, two capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein were developed.
Journal ArticleDOI
Development of a bispecific immune engager using a recombinant malaria protein
Mie A. Nordmaj,Mie A. Nordmaj,Morgan E. Roberts,Emilie S. Sachse,Emilie S. Sachse,Robert Dagil,Robert Dagil,Anne Poder Andersen,Anne Poder Andersen,Nanna Skeltved,Nanna Skeltved,Kaare V. Grunddal,Kaare V. Grunddal,Sayit Mahmut Erdoğan,Sayit Mahmut Erdoğan,Swati Choudhary,Swati Choudhary,Tobias Gustsavsson,Tobias Gustsavsson,Maj Sofie Ørum-Madsen,Igor Moskalev,Weihua Tian,Zhang Yang,Thomas Mandel Clausen,Thomas Mandel Clausen,Thomas Mandel Clausen,Thor G. Theander,Thor G. Theander,Mads Daugaard,Morten Nielsen,Morten Nielsen,Ali Salanti,Ali Salanti +32 more
TL;DR: In this article, a bispecific immune engager, V-aCD3, based on recombinant VAR2CSA as the cancer targeting moiety and an anti-CD3 single-chain variable fragment linked to a single chain Fc as the immune enforcer was presented.